In last trading session, Passage Bio Inc (NASDAQ:PASG) saw 0.45 million shares changing hands with its beta currently measuring 1.65. Company’s recent per share price level of $0.33 trading at $0.0 or 0.33% at ring of the bell on the day assigns it a market valuation of $20.58M. That closing price of PASG’s stock is at a discount of -303.03% from its 52-week high price of $1.33 and is indicating a premium of 21.21% from its 52-week low price of $0.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.33 million shares which gives us an average trading volume of 275.94K if we extend that period to 3-months.
For Passage Bio Inc (PASG), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Passage Bio Inc (NASDAQ:PASG) trade information
Upright in the green during last session for gaining 0.33%, in the last five days PASG remained trading in the red while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $0.33 price level, adding 15.62% to its value on the day. Passage Bio Inc’s shares saw a change of -63.70% in year-to-date performance and have moved -15.32% in past 5-day. Passage Bio Inc (NASDAQ:PASG) showed a performance of -7.98% in past 30-days. Number of shares sold short was 1.78 million shares which calculate 5.04 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 94.5% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -1718.18% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1718.18% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -1.48% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 31.21% while estimates for its earnings growth in next 5 years are of 44.74%.
Passage Bio Inc (NASDAQ:PASG)’s Major holders
Insiders are in possession of 0.21% of company’s total shares while institution are holding 58.25 percent of that, with stock having share float percentage of 58.37%. Investors also watch the number of corporate investors in a company very closely, which is 58.25% institutions for Passage Bio Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at PASG for having 10.12 million shares of worth $8.04 million. And as of 2024-06-30, it was holding 17.9847 of the company’s outstanding shares.
The second largest institutional holder is VESTAL POINT CAPITAL, LP, which was holding about 6.05 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.7504 of outstanding shares, having a total worth of $4.81 million.
